NT-0300

N/A

Report date: 2022/03/30 14:29:19
NME

Base Information

Drug NameNT-0300
Drug Alias NameNT-0300
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionKRAS G12D inhibitorsKRAS G12V inhibitors
TargetsKRAS G12DKRAS G12V
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeubase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeubase Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A